Study Status: Not yet recruiting
Recruit Status: Not yet recruiting
Study Type: Interventional
Official Title: Pilot Study of the MEK1/2 Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) for Adults With Neurofibromatosis Type 1(NF1) and Dermal Neurofibromas (DN)
Brief Summary: This pilot clinical trial studies how well selumetinib works in treating patients with neurofibromatosis type 1 and dermal neurofibromas. Selumetinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.